Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Melanoma
57%
Fluorodeoxyglucose F 18
57%
Positron Emission Tomography
38%
Diagnostic Performance
38%
Malignant Neoplasm
29%
Radiomics
26%
Fluorine-18
23%
Gallium 68
23%
Single-Photon Emission Computed Tomography
23%
Prostate Cancer
22%
Treatment Response
20%
Bone Metastasis
19%
Bone Scintigraphy
19%
Adrenal Metastasis
19%
Myocardial Perfusion Imaging
19%
Brain Metastasis
19%
Meta-Analysis
19%
Systematic Review
19%
Lutetium 177
19%
Immunotherapy
19%
Agents Acting on the Eye
19%
Uvea Melanoma
19%
Mesothelioma
19%
Primary Hyperparathyroidism
19%
Gastrin Releasing Peptide Receptor
19%
Progression Free Survival
19%
Lung Cancer
19%
Clinical Decision Making
19%
Neoadjuvant Chemotherapy
16%
Hazard Ratio
15%
Sensitivity and Specificity
12%
Abdominal Cancer
10%
Cancer
10%
Prostate Adenocarcinoma
9%
Tumor Imaging
9%
Survival Analysis
8%
Lymph Node Metastasis
8%
Histopathology
7%
Retrospective Study
6%
Neoplasm
6%
Diseases
5%
Prostate Specific Antigen
5%
Pharmacology, Toxicology and Pharmaceutical Science
Polyethylene Terephthalate
76%
Fluorodeoxyglucose F 18
57%
Gallium 68
42%
Malignant Neoplasm
23%
Prostate Cancer
22%
Coronary Artery Disease
19%
Ischemic Heart Disease
19%
Melanoma
19%
Lutetium 177
19%
Brain Metastasis
19%
Bone Metastasis
19%
Bile Duct Carcinoma
19%
Chemotherapy
19%
Progression Free Survival
19%
Radiopharmaceutical Agent
13%
Guanosine Phosphate
9%
Abdominal Cancer
6%
Retrospective Study
5%
Disease
5%
Prostate Specific Antigen
5%